中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2010年
12期
1332-1335
,共4页
叶海昀%金陈进%田臻%徐莉%赖坤贝%钟晓菁%陈丽蓉
葉海昀%金陳進%田臻%徐莉%賴坤貝%鐘曉菁%陳麗蓉
협해윤%금진진%전진%서리%뢰곤패%종효정%진려용
光动力疗法%脉络膜血管瘤%视力
光動力療法%脈絡膜血管瘤%視力
광동력요법%맥락막혈관류%시력
Ccircumscribed choroidal haemangioma%Pphotodynamic therapy%V%visual acuity
目的 评价光动力疗法(PDT)治疗孤立性脉络膜血管瘤的临床效果.方法 经眼底检查、荧光素眼底血管造影、B超及OCT检查确诊的孤立性脉络膜血管瘤患者21例21只眼,伴有不同程度渗出性视网膜脱离和黄斑水肿.患者术前最佳矫正视力为HM/眼前~0.8,B超检查瘤体最大直径6.7~15.6mm(平均8.9mm).光敏剂为维替泊芬,激光波长689nm,功率密度600mW/cm2,曝光时间166s.结果 所有患者经1~2次(平均1.3)光动力治疗,光斑直径4200~7500μm,1~5个光斑(平均1.5个).随访6~73个月,最佳矫正视力提高者7只眼(33.3%),视力稳定者14只眼(66.7%),无视力明显下降病例.B超检查显示瘤体变小甚至萎缩,FFA、OCT显示渗出性视网膜脱离及黄斑水肿吸收.结论 光动力疗法治疗孤立性脉络膜血管瘤安全有效,可使瘤体萎缩,视网膜内积液及视网膜下液吸收,保存或提高患者视力.
目的 評價光動力療法(PDT)治療孤立性脈絡膜血管瘤的臨床效果.方法 經眼底檢查、熒光素眼底血管造影、B超及OCT檢查確診的孤立性脈絡膜血管瘤患者21例21隻眼,伴有不同程度滲齣性視網膜脫離和黃斑水腫.患者術前最佳矯正視力為HM/眼前~0.8,B超檢查瘤體最大直徑6.7~15.6mm(平均8.9mm).光敏劑為維替泊芬,激光波長689nm,功率密度600mW/cm2,曝光時間166s.結果 所有患者經1~2次(平均1.3)光動力治療,光斑直徑4200~7500μm,1~5箇光斑(平均1.5箇).隨訪6~73箇月,最佳矯正視力提高者7隻眼(33.3%),視力穩定者14隻眼(66.7%),無視力明顯下降病例.B超檢查顯示瘤體變小甚至萎縮,FFA、OCT顯示滲齣性視網膜脫離及黃斑水腫吸收.結論 光動力療法治療孤立性脈絡膜血管瘤安全有效,可使瘤體萎縮,視網膜內積液及視網膜下液吸收,保存或提高患者視力.
목적 평개광동력요법(PDT)치료고립성맥락막혈관류적림상효과.방법 경안저검사、형광소안저혈관조영、B초급OCT검사학진적고립성맥락막혈관류환자21례21지안,반유불동정도삼출성시망막탈리화황반수종.환자술전최가교정시력위HM/안전~0.8,B초검사류체최대직경6.7~15.6mm(평균8.9mm).광민제위유체박분,격광파장689nm,공솔밀도600mW/cm2,폭광시간166s.결과 소유환자경1~2차(평균1.3)광동력치료,광반직경4200~7500μm,1~5개광반(평균1.5개).수방6~73개월,최가교정시력제고자7지안(33.3%),시력은정자14지안(66.7%),무시력명현하강병례.B초검사현시류체변소심지위축,FFA、OCT현시삼출성시망막탈리급황반수종흡수.결론 광동력요법치료고립성맥락막혈관류안전유효,가사류체위축,시망막내적액급시망막하액흡수,보존혹제고환자시력.
Objective To assess the efficacy and safety of photodynamic therapy (PDT) for the treatment of circumscribed choroidal haemangioma (CCH) in Chinese patients. Methods Of 21 patients (21eyes))with CCH were treated with PDT (visudyne 6 mg/m2 body surface area and a light dose of 100 J/cm2) at 689 nm diode laser applied over 166 seconds per spot. Overlapping multiple spots were applied to cover the entire tumor surface. The best-corrected visual acuity on baseline was ranged from HM to 0.8 and pretreatment tumor diameter was 6.7~15.6mm (mean 8.9mm)). Periodic follow-up with ophthalmoscopy, ultrasonography B scan,optical coherence tomography (OCT) and angiographic studies were performed. Results All patients underwent 1 or 2 (mean 1.3) times PDT treatment with 1~5 (mean 1.5) spots in diameter of4200~7500μm. Visual acuity improved in seven of 21 eyes (33.3%), remained stable in 14 eyes (66.7%) during 6~73 months'follow-up (mean 28 months). No case with markedly decreased visual acuity was observed. The tumors were markedly regressed in ultrasonography B scan, OCT and fundus fluorescein angiography (FFA) showed residual leakage were obviously resolved with the overlying retinal vessels remained unaffected. There was no ocular or systemic complication. Conclusion PDT is a safe and effective treaunent modality for circumscribed choroidal haemangioma. It may regress the tumor, restore or improve the visual acuity without causing significant ocular or systemic side-effects.